EUVIMEDEUVIMED entdecken
Übersichtsarbeit

After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?

Ian J Cohen iD

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31608 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Ian J Cohen. Beteiligte Einrichtung: The Rina Zaizov Dept of Pediatric Hematology Oncology, The Schneider Children's Hospital of Israel, Petah Tikva and the Sackler Faculty of Medicine, …. Hauptthemen laut MEDLINE: Methotrexate, Leucovorin, Antimetabolites, Antineoplastic, Folic Acid Antagonists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After 75 years of clinical use of folic acid antagonists such as methotrexate, relevant pharmacological data currently important for the effective and safe use of methotrexate were reviewed to see if it is possible to improve outcomes. Specifically, to improve how high‐dose methotrexate (HD‐MTX) can be given safely, what doses of MTX (methotrexate) are adequate to achieve therapeutic levels, and what is the appropriate folinic acid (FA) dose for effective rescue. This review is based on 50 years of personal experience with the use of HD‐MTX in published literature. Many pharmacologic studies were performed over 50 years ago, but are still relevant and stand up to scrutiny today. What should be considered HD‐MTX and how it can be given safely and effectively without late toxicity are presented. The variables responsible for effective folinic acid rescue, especially the doses of MTX and folinic acid and the time to start of rescue, are discussed. Understanding these highlighted aspects of therapy could help to prevent acute toxicity, improve treatment results, and prevent late effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateLeucovorinAntimetabolites, AntineoplasticFolic Acid AntagonistsHumans

Stichwörter der Autor:innen

adequate folinic acidadequate methotrexatetreatment safety

Substanzen

MethotrexateLeucovorinAntimetabolites, AntineoplasticFolic Acid Antagonists

Autor:innen und Institutionen

  • The Rina Zaizov Dept of Pediatric Hematology Oncology, The Schneider Children's Hospital of Israel, Petah Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.

ORCID-Profile: Ian J Cohen

Zitieren

APA

Cohen, I. J. (2025). After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31608

Vancouver

Cohen IJ. After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31608

BibTeX
@article{Cohen2025,
  author = {Cohen, Ian J},
  title = {After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31608}
}
Kostenlos starten →